Also known as: Bpc-157, 137525-51-0, Bpc 157, Bepecin, Bpc 15, Pl-10 Molecular Formula C 62 H 98 N 16 O 22 Molecular Weight 1419.5 g/mol InChI Key HEEWEZGQMLZMFE-RKGINYAYSA-N Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial)
Statistically, depression is linked with the following chronic diseases:[ref] cardiovascular disease cerebrovascular disease high blood pressure type 2 diabetes, autoimmune diseases Immune system impairment cancer In other words, depression is not all in your head

Evidence Level Strong preclinical What to Expect Week 1-2 What you might notice Reduced inflammation Less pain at injury site Improved gut comfort (if used for digestive issues) What's normal Subtle changesdon't expect dramatic results yet Some users feel nothing this early What's next Continue protocol Maintain consistent timing Week 3-4 What you might notice Noticeable improvement in injury healing Increased mobility Better function in affected area Significant gut symptom relief What's normal This is when most users see clear benefits Progress may be gradual, not sudden What's next Assess if dose adjustment needed Continue if seeing progress Week 5-6+ What you might notice Substantial or complete healing Return to normal activity Lasting improvements What's normal Healing timeline varies by injury severity Some chronic conditions need longer What's next Consider stopping if healed Take 2-4 week break Can restart if needed Signs It's Working For injuries Less pain at rest Less pain with movement Improved range of motion Faster recovery between workouts Reduced swelling For gut issues Less bloating Reduced pain after eating More regular digestion Decreased symptoms overall Not Seeing Results

Constipation Tirzepatide slows gastric motility, which frequently causes constipation
Avoid aspirin unless advised by your clinician because it can increase bleeding risk